Bio-Techne Corp (TECH) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bio-Techne Corp (TECH) has a cash flow conversion efficiency ratio of 0.045x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($95.42 Million) by net assets ($2.11 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Bio-Techne Corp for the company's overall valuation and market capitalisation.
Bio-Techne Corp - Cash Flow Conversion Efficiency Trend (1990–2026)
This chart illustrates how Bio-Techne Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Bio-Techne Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bio-Techne Corp ranked by their cash flow conversion efficiency. Explore TECH cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ZTO EXPRESS (CAYMAN)
F:ZTOB
|
N/A |
|
Comerica Incorporated
NYSE:CMA
|
-0.035x |
|
American Homes 4 Rent
NYSE:AMH
|
0.028x |
|
ENKA Insaat ve Sanayi AS
IS:ENKAI
|
0.022x |
|
Hecla Mining Company
NYSE:HL
|
0.065x |
|
A.P.MOELL-M.B U.ADR 1/200
F:DP4H
|
0.044x |
|
Indian Railway Finance Corporation Limited
NSE:IRFC
|
-0.247x |
|
Gaming & Leisure Properties
NASDAQ:GLPI
|
0.065x |
Annual Cash Flow Conversion Efficiency for Bio-Techne Corp (1990–2026)
The table below shows the annual cash flow conversion efficiency of Bio-Techne Corp from 1990 to 2026. View Bio-Techne Corp (TECH) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-06-30 | $2.11 Billion | $292.07 Million | 0.139x | -7.55% |
| 2025-06-30 | $1.92 Billion | $287.56 Million | 0.150x | +3.70% |
| 2024-06-30 | $2.07 Billion | $298.98 Million | 0.145x | +11.71% |
| 2023-06-30 | $1.97 Billion | $254.39 Million | 0.129x | -32.35% |
| 2022-06-30 | $1.70 Billion | $325.27 Million | 0.191x | -14.68% |
| 2021-06-30 | $1.57 Billion | $352.16 Million | 0.224x | +50.85% |
| 2020-06-30 | $1.38 Billion | $205.22 Million | 0.149x | -4.65% |
| 2019-06-30 | $1.17 Billion | $181.62 Million | 0.156x | -1.30% |
| 2018-06-30 | $1.08 Billion | $170.37 Million | 0.158x | +4.64% |
| 2017-06-30 | $950.83 Million | $143.45 Million | 0.151x | -7.80% |
| 2016-06-30 | $879.28 Million | $143.87 Million | 0.164x | -0.56% |
| 2015-06-30 | $846.93 Million | $139.36 Million | 0.165x | -4.32% |
| 2014-06-30 | $795.26 Million | $136.76 Million | 0.172x | +2.65% |
| 2013-06-30 | $737.54 Million | $123.56 Million | 0.168x | -10.85% |
| 2012-06-30 | $674.44 Million | $126.75 Million | 0.188x | -13.40% |
| 2011-06-30 | $586.12 Million | $127.19 Million | 0.217x | -2.13% |
| 2010-06-30 | $501.79 Million | $111.26 Million | 0.222x | -9.08% |
| 2009-06-30 | $456.48 Million | $111.32 Million | 0.244x | +3.02% |
| 2008-06-30 | $487.13 Million | $115.32 Million | 0.237x | +14.48% |
| 2007-06-30 | $437.65 Million | $90.50 Million | 0.207x | -17.77% |
| 2006-06-30 | $340.35 Million | $85.59 Million | 0.251x | -9.50% |
| 2005-06-30 | $267.87 Million | $74.43 Million | 0.278x | +26.07% |
| 2004-06-30 | $297.43 Million | $65.55 Million | 0.220x | -3.58% |
| 2003-06-30 | $236.62 Million | $54.09 Million | 0.229x | +70.63% |
| 2002-06-30 | $206.52 Million | $27.67 Million | 0.134x | -48.67% |
| 2001-06-30 | $177.66 Million | $46.37 Million | 0.261x | -4.90% |
| 2000-06-30 | $141.15 Million | $38.74 Million | 0.274x | -6.45% |
| 1999-06-30 | $96.80 Million | $28.40 Million | 0.293x | -7.79% |
| 1998-06-30 | $63.80 Million | $20.30 Million | 0.318x | +22.44% |
| 1997-06-30 | $48.10 Million | $12.50 Million | 0.260x | +3.15% |
| 1996-06-30 | $38.90 Million | $9.80 Million | 0.252x | +1.81% |
| 1995-06-30 | $29.50 Million | $7.30 Million | 0.247x | -9.66% |
| 1994-06-30 | $23.00 Million | $6.30 Million | 0.274x | +8.35% |
| 1993-06-30 | $17.80 Million | $4.50 Million | 0.253x | -27.40% |
| 1992-06-30 | $11.20 Million | $3.90 Million | 0.348x | +21.88% |
| 1991-06-30 | $6.30 Million | $1.80 Million | 0.286x | +19.48% |
| 1990-06-30 | $4.60 Million | $1.10 Million | 0.239x | -- |
About Bio-Techne Corp
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. It operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of l… Read more